International Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Exploratory Phase Ib/II Trial Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of RB0026 Injection in Healthy Preterm and Term Infants in China

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129147) titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Exploratory Phase Ib/II Trial Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of RB0026 Injection in Healthy Preterm and Term Infants in China' on July 31.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Chengdu Women and Children's Medical Center

Condition: Respiratory syncytial virus

Intervention: Low-dose RB0026 injection group:Single intramuscular injection of 1 ml (100 mg RB0026) Medium-Dose RB0026 Injection Group:Single intramuscular injection of 1.5 ml (150 mg RB00...